HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.

Abstract
Some patients developed Guillain-Barré syndrome (GBS) after being given bovine gangliosides. Patients with GBS subsequent to Campylobacter jejuni enteritis frequently have IgG antibody to GM1 ganglioside. Miller Fisher syndrome (MFS), a variant of GBS, is associated with IgG antibody to GQ1b ganglioside. The existence of molecular mimicry between GM1 and lipopolysaccharide of C. jejuni isolated from a GBS patient and that between GQ1b and C. jejuni lipopolysaccharides from patients with MFS are shown herein. The molecular mimicry between infectious agents and gangliosides may function in the production of anti-ganglioside antibodies and the development of GBS and MFS.
AuthorsN Yuki
JournalThe Journal of infectious diseases (J Infect Dis) Vol. 176 Suppl 2 Pg. S150-3 (Dec 1997) ISSN: 0022-1899 [Print] United States
PMID9396700 (Publication Type: Journal Article, Review)
Chemical References
  • Antibodies, Bacterial
  • Autoantibodies
  • Epitopes
  • Gangliosides
  • Immunoglobulin G
  • Lipopolysaccharides
  • O Antigens
Topics
  • Antibodies, Bacterial (immunology)
  • Autoantibodies (immunology)
  • Campylobacter Infections (complications, immunology, microbiology)
  • Campylobacter jejuni (classification, immunology)
  • Enteritis (complications, immunology, microbiology)
  • Epitopes (immunology)
  • Gangliosides (immunology)
  • Humans
  • Immunoglobulin G (immunology)
  • Lipopolysaccharides (immunology)
  • Miller Fisher Syndrome (etiology, immunology, microbiology)
  • Molecular Mimicry
  • O Antigens (immunology)
  • Polyradiculoneuropathy (etiology, immunology, microbiology)
  • Serotyping

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: